The use of directional interstitial sources to improve dosimetry in breast brachytherapy

Medical Physics

Volumn 35, Issue 1, 2008, Pages 240-247

  Lin, Liyong ^a   Patel, Rakesh R ^b   Thomadsen, Bruce R ^b   Henderson, Douglass L ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Brachytherapy; Breast; Dosimetry; HDR; LDR

Indexed keywords

ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY;

BRACHYTHERAPY; BREAST; DIRECTIONAL SOURCES; DOSIMETRIC PARAMETER; EMITTING RADIATION; INTENSITY OF RADIATION; INTERNAL RADIATION; INTERSTITIAL BRACHYTHERAPY;

DOSIMETRY;

IODINE 125; IRIDIUM 192;

ARTICLE; BREAST CANCER; DOSIMETRY; FEASIBILITY STUDY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOISOTOPE THERAPY; TREATMENT PLANNING;

EID: 37549058017     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2815623     Document Type: Article

References (23)

1. F. Vicini, " Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial., " Int. J. Radiat. Oncol. Biol. Phys. 38, 301-330 (1997). 0360-3016
2. D. Arthur, " Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience., " Int. J. Radiat. Oncol. Biol. Phys. 56, 681-689 (2003). 0360-3016
3. P. Chen, " Long-term cosmetic results and toxicity after accelerated partial breast irradiation., " Cancer 106, 991-999 (2006). 0008-543X
4. R. Patel and R. Das, " Image-guided breast brachytherapy: an alternative to whole-breast radiotherapy., " Lancet Oncol. 7, 407-415 (2006). 1470-2045
5. D. Wazer, " Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose rate interstitial brachytherapy., " Int. J. Radiat. Oncol. Biol. Phys. 64, 489-495 (2006). 0360-3016
6. B. Keller, " A permanent breast seed implant as partial breast irradiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 iostopes based on radiation safety considerations., " Int. J. Radiat. Oncol. Biol. Phys. 62, 358-365 (2005). 0360-3016
7. J. P. Pignol, " First report of a permanent breast P 103 d seed implant as adjuvant radiation treatment for early stage breast cancer., " Int. J. Radiat. Oncol. Biol. Phys. 64, 176-181 (2006). 0360-3016
8. S. N. Rustgi and S. S. Hahn, " Advantages of using high activity 125I seeds in temporary interstitial breast implants., " Med. Dosim. 17, 217-220 (1992). 0958-3947
9. F. Perera, " TLD skin dose measurements and acute and late effects after lumpectomy an high-dose-rate brachytherapy only for early breast cancer., " Int. J. Radiat. Oncol. Biol. Phys. 62, 1283-1290 (2005). 0360-3016
10. L. Lin, V. Chaswal, B. Thomadsen, and D. Henderson, " Assessment of a prostate treatment plan using directional brachytherapy sources., " Med. Phys. 32, 2098 (1999) (abstract). 0094-2405
11. L. Lin, R. Patel, B. Thomadsen, and D. Henderson, " The use of directional interstitial sources to reduce skin dose in breast brachytherapy., " Med. Phys. 33, 2206 (2006) (abstract). 0094-2405
12. L. Lin, B. R. Thomadsen, M. A. Ritter, J. F. Fowler, R. R. Patel, S. Bentzen, and D. L. Henderson, " New directional brachytherapy sources and repair half-time data indicate monotherapy for intermediate risk T2b and high risk T2c prostate tumors., " Int. J. Radiat. Oncol. Biol. Phys. 66, S75-S76 (2006) (abstract). 0360-3016
13. R. Das, R. Patel, H. Shah, H. Odau, and R. R. Kuske, " 3D T -based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance., " Int. J. Radiat. Oncol. Biol. Phys. 59, 1224-1228 (2004). 0360-3016
14. F. Waterman and D. Holcomb, " Dose distributions by a shielded vagina applicators using high-activity iridium-192 source., " Med. Phys. 0094-2405 10.1118/1.597241 21, 101-106 (1999).
15. http://physics.nist.gov/PhysRefData/XrayMassCoef/ (last access 7/30/2007).
16. M. Rivard, " Update of AAPM Task Group No. 43 Report: A revised AAPM protococol for brachytherapy dose calculation., " Med. Phys. 0094-2405 10.1118/1.1646040, 31, 633-674 (2004), M. Rivard, "erratum Med. Phys. 31, 3532-3533 (2004).
17. M. Rivard, " Update of AAPM Task Group No. 43 Report: A revised AAPM protococol for brachytherapy dose calculation., " Med. Phys. 0094-2405 10.1118/1.1646040, 31, 633-674 (2004), M. Rivard, "erratum Med. Phys. 31, 3532-3533 (2004).
18. T. Bohm, P. Deluca, and L. DeWard, " Brachytherapy dosimetry of I 125 and P 103 d sources using an updated cross section library for the MCNP Monte Carlo transport code., " Med. Phys. 0094-2405 10.1118/1.1562942 30, 701-711 (2003).
19. K. Sowards and A. S. Meigooni, " A Monte Carlo evaluation of the dosimetric characteristics of the Best Model 2301 125I brachytherapy source., " Appl. Radiat. Isot. 0969-8043 10.1016/S0969-8043(02)00124-0 57, 327-333 (2002).
20. R. Dale, " Dose-rate effects in targeted radiotherapy., " Phys. Med. Biol. 0031-9155 10.1016/S0360-3016(98)00364-2 41, 1871-1884 (1996).
21. S. Seltzer, " New national standard air-kerma-strength standards for I 125 and P 103 d brachytherapy seeds., " J. Res. Inst. Stand. Technol. 108, 337-358 (2003).
22. L. A. Dewerd, " Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon emitting brachytherapy sources: Recommendations of calibration laboratory Accreditation Subcommittee of American Association of Physicists in Medicine., " Med. Phys. 0094-2405 10.1118/1.1645681 31, 675-681 (2004).
23. V. Chaswal, " Interstitial prostate implant brachytherapy using an automated, 3-d greedy heuristic optimization and I-125 directional sources., " accepted by the American Brachytherapy Society Annual Meeting, 2007 (abstract).